In this episode, Tej Singh interviews Ben Liu, the Co-founder & CEO of TrialSpark, which takes the guesswork and growing pains out of starting pharmaceutical clinical trials by overseeing all aspects of clinical research, from recruitment and set-up to maintenance and completion. They use technology to identify pockets of potential patients outside the typical test area of large cities and universities and help equip doctors with the infrastructure and oversight to efficiently run a clinical trial to help those patients.

Trialspark's investors include Sequoia, Thrive Capital, and KPCB's John Doerr. Ben is a Rhode's Scholar; he received his undergraduate degree from Yale, his Master's from Cambridge, and Doctorate degree from Oxford.